TheraCryf (LSE:TCF) Other Current Liabilities : £0.00 Mil (As of Sep. 2024)

View and export this data going back to 2015. Start your Free Trial

What is TheraCryf Other Current Liabilities?

TheraCryf's other current liabilities for the quarter that ended in Sep. 2024 was £0.00 Mil.

TheraCryf's quarterly other current liabilities increased from Sep. 2023 (£0.00 Mil) to Mar. 2024 (£0.32 Mil) but then declined from Mar. 2024 (£0.32 Mil) to Sep. 2024 (£0.00 Mil).

TheraCryf's annual other current liabilities increased from Mar. 2022 (£0.32 Mil) to Mar. 2023 (£0.39 Mil) but then declined from Mar. 2023 (£0.39 Mil) to Mar. 2024 (£0.32 Mil).

TheraCryf Other Current Liabilities Historical Data

The historical data trend for TheraCryf's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TheraCryf Other Current Liabilities Chart

TheraCryf Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Other Current Liabilities

Get a 7-Day Free Trial

0.11

0.17

0.32

0.39

0.32

TheraCryf Semi-Annual Data
	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24
Other Current Liabilities	Get a 7-Day Free Trial															-	0.39	-	0.32	-

TheraCryf Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

TheraCryf Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of TheraCryf's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

TheraCryf Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TheraCryf PLC (LSE:TCF) » Definitions » Other Current Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

Congleton Road, Alderley Park, Nether Alderley, Cheshire, GBR, SK10 4TG

Website

https://www.evgen.com

TheraCryf PLC is a clinical-stage biotechnology company focused on profitable segments in oncology and neuropsychiatry. The company's lead clinical asset, SFX-01 is a patented form of delivering sulforaphane, which could be used in the treatment of a number of cancers, neurodevelopmental disorders, and other diseases.